Bone Scan Index (BSI) is an imaging biomarker that can support physicians to determine treatment response and to prognosticate survival in patients with advanced prostate cancer and bone metastases.
The aim of this web site is to collate and present all the documentation, information and knowledge available about
Bone Scan Index.
This web portal is intended as an educational resource for healthcare providers. It may include information about products or uses that have not been approved by the U.S. Food and Drug Administration.
If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.
OK